165 related articles for article (PubMed ID: 12846401)
1. Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.
Chapman RW
Dig Liver Dis; 2003 May; 35(5):306-8. PubMed ID: 12846401
[No Abstract] [Full Text] [Related]
2. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
[No Abstract] [Full Text] [Related]
3. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
[TBL] [Abstract][Full Text] [Related]
4. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Smith T; Befeler AS
Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy for primary sclerosing cholangitis.
Wong GL; Wong VW
Aliment Pharmacol Ther; 2011 Nov; 34(9):1135-6; discussion 1136-7. PubMed ID: 21981734
[No Abstract] [Full Text] [Related]
6. Ulcerative colitis and an abnormal cholangiogram.
Nguyen DL; Lazaridis KN
Cleve Clin J Med; 2011 May; 78(5):306-11. PubMed ID: 21536825
[No Abstract] [Full Text] [Related]
7. Pathogenesis and medical therapy of primary sclerosing cholangitis.
van Milligen de Wit AW
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
[No Abstract] [Full Text] [Related]
8. Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis.
Santander C; Moreno-Otero R
Aliment Pharmacol Ther; 2012 Apr; 35(7):846; discussion 847. PubMed ID: 22404405
[No Abstract] [Full Text] [Related]
9. Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?).
Tabibian JH; Lindor KD
Hepatology; 2014 Sep; 60(3):785-8. PubMed ID: 24752961
[No Abstract] [Full Text] [Related]
10. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
Zimmer V; Lammert F
EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
[No Abstract] [Full Text] [Related]
11. Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
Chapman RW
Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):74-5. PubMed ID: 20134486
[No Abstract] [Full Text] [Related]
12. URSO not so good for PSC.
Petruff CA
Inflamm Bowel Dis; 1998 May; 4(2):172-3. PubMed ID: 9589304
[No Abstract] [Full Text] [Related]
13. Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period.
De Maria N; Colantoni A; Rosenbloom E; Van Thiel DH
Hepatogastroenterology; 1996; 43(12):1472-9. PubMed ID: 8975951
[TBL] [Abstract][Full Text] [Related]
14. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534
[No Abstract] [Full Text] [Related]
15. Ursodiol for all?
Lee SD; Surawicz CM
Am J Gastroenterol; 2001 Dec; 96(12):3437-8. PubMed ID: 11774966
[No Abstract] [Full Text] [Related]
16. Primary sclerosing cholangitis: providing a safe and effective treatment.
Imam MH; Lindor KD
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):255-7. PubMed ID: 22646247
[No Abstract] [Full Text] [Related]
17. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
18. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares RodrÃguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
19. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy.
Fong DG; Lindor KD
Am J Gastroenterol; 2000 Aug; 95(8):1861-2. PubMed ID: 10950026
[No Abstract] [Full Text] [Related]
20. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
